Recent Updates
Recently added Catalysts
MBX Positive Sentiment Score: 70/100

MBX Biosciences to Participate in Piper Sandler 35th Annual Healthcare Conference

Wednesday, November 15, 2023 1 min read
Key Takeaway: MBX Biosciences, a clinical stage biopharmaceutical company, announced its participation in the Piper Sandler 35th Annual Healthcare Conference. Kent Hawryluk, the company's CEO, will present at the event on November 29th, 2023, at 9:10 a.m. ET and will also host one-on-one investor meetings. This participation aims to enhance investor interest and showcase their Precision Endocrine Peptide therapeutics.

Market Sentiment Analysis

POSITIVE FACTORS

  • MBX Biosciences is actively participating in a prominent healthcare conference.
  • The event provides an opportunity for investor engagement and exposure.
  • Presentation at the conference may increase visibility for MBX's clinical advancements.

Full Press Release Details

CARMEL, Ind., Nov. 15, 2023 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of endocrine disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, will present at the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29th, 2023, at 9:10 a.m. Eastern Time and will host 1-on-1 investor meetings.
About MBX Biosciences
ian.stone@evokegroup.com
ikoffler@lifesciadvisors.com

Frequently Asked Questions

What company is presenting at the Piper Sandler Conference?

MBX Biosciences, Inc. will present at the conference.

When will the presentation at the conference take place?

The presentation is scheduled for November 29, 2023, at 9:10 a.m. ET.

Who is the CEO of MBX Biosciences?

Kent Hawryluk is the President and CEO of MBX Biosciences.

What type of therapeutics is MBX Biosciences developing?

They are developing Precision Endocrine Peptide™ (PEP™) therapeutics.

What issues are targeted by MBX Biosciences' therapeutics?

Their therapeutics aim to treat various endocrine disorders.

Tags: MBX Viatris Investor Conferences Healthcare biopharmaceutical investor meetings Piper Sandler healthcare conference
Last updated: Nov 15, 2023